Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00962728 · ClinicalTrials.gov registry record · NA

Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)

A NA study of Postural Tachycardia Syndrome and Postural Orthostatic Tachycardia Syndrome, sponsored by Alfredo Gamboa.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00962728 is a NA study of Postural Tachycardia Syndrome and Postural Orthostatic Tachycardia Syndrome that is active but no longer recruiting, run by Alfredo Gamboa. The registered enrollment target is 30 participants, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00962728, a NA study of Postural Tachycardia Syndrome and Postural Orthostatic Tachycardia Syndrome, is active but no longer recruiting, sponsored by Alfredo Gamboa.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The investigators will test whether breathing through an inspiratory resistance device will improve the ability to be upright and decrease heart rate increases on standing in patients with postural tachycardia syndrome.

Interventions

  • DEVICE Inspiratory Threshold Device (Res-Q-Gard ITD)
  • DEVICE Sham Inspiratory Threshold Device

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2009-07
Est. Completion 2026-12
Phase NA

Sponsor

Alfredo Gamboa

1 total trials

What the Registry Record Tells You About NCT00962728

The ClinicalTrials.gov registry entry for NCT00962728 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 81-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (63% lower). The listed sponsor is Alfredo Gamboa, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Inspiratory Threshold Device (Res-Q-Gard ITD) is the first listed.

NCT00962728 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT00962728 about?

NCT00962728 is a clinical study titled "Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)". The investigators will test whether breathing through an inspiratory resistance device will improve the ability to be upright and decrease heart rate increases on standing in patients with postural tachycardia syndrome.

What is the current status of trial NCT00962728?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2009-07. Estimated completion is 2026-12.

What conditions does trial NCT00962728 study?

This clinical trial studies the following conditions: Postural Tachycardia Syndrome, Postural Orthostatic Tachycardia Syndrome.

What interventions are being tested in trial NCT00962728?

The interventions under investigation include: Inspiratory Threshold Device (Res-Q-Gard ITD) (DEVICE), Sham Inspiratory Threshold Device (DEVICE).

Who is sponsoring clinical trial NCT00962728?

This trial is sponsored by Alfredo Gamboa, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00962728 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postural Tachycardia Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.